Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil
- PMID: 16200634
- DOI: 10.1002/pbc.20624
Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil
Abstract
Background: Several reports refer to an increased frequency of adrenal cortex tumors (ACT) among children in Southern Brazil, yet all data have been derived from hospital-based registries. An inherited germline mutation in the p53 gene (TP53 R337H) is detected in virtually all children with ACT in this region and accounts for the excess cases observed.
Procedure: We reviewed all death certificates that mentioned ACT or adrenal neuroblastoma (NB) and which were reported to the Paraná State Department of Health between 1998 and 2003, for individuals younger than 15 years who resided in the Curitiba metropolitan region.
Results: Eight deaths from ACT and ten from NB were identified. The age-standardized mortality rate per million children <15 years of age in the Curitiba metropolitan region during the years 1998-2003 was 1.6 (95% confidence interval (CI) 1.4, 1.8) for ACT and 2.3 (95% CI 2.0, 2.5) for NB. The ratio of the adrenal NB and ACT age-adjusted mortality rates was 1.43. The incidence of ACT estimated from the mortality data, assuming an ACT survival rate of 0.542, was 3.5 (95% CI 2.9, 4.2).
Conclusions: Our investigation of population-based mortality confirms the evidence from hospital-based registries of a clustering of ACT in Southern Brazil. In addition, our data suggest that the incidence of ACT in this region is about 12-18 times the incidence reported in the United States and Europe.
Copyright 2006 Wiley-Liss, Inc.
Similar articles
-
Biology, clinical characteristics, and management of adrenocortical tumors in children.Pediatr Blood Cancer. 2005 Sep;45(3):265-73. doi: 10.1002/pbc.20318. Pediatr Blood Cancer. 2005. PMID: 15747338 Review.
-
Molecular epidemiology of adrenocortical tumors in southern Brazil.Mol Cell Endocrinol. 2012 Mar 31;351(1):44-51. doi: 10.1016/j.mce.2011.10.019. Epub 2011 Oct 25. Mol Cell Endocrinol. 2012. PMID: 22056871 Review.
-
Inheritance of R337H p53 gene mutation in children with sporadic adrenocortical tumor.Horm Metab Res. 2005 Apr;37(4):231-5. doi: 10.1055/s-2005-861373. Horm Metab Res. 2005. PMID: 15952083
-
Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.Mol Cell Endocrinol. 2012 Mar 31;351(1):52-7. doi: 10.1016/j.mce.2011.09.040. Epub 2011 Oct 14. Mol Cell Endocrinol. 2012. PMID: 22019901 Review.
-
Composite adrenal anaplastic neuroblastoma and virilizing adrenocortical tumor with germline TP53 R248W mutation.Pediatr Blood Cancer. 2008 Mar;50(3):681-3. doi: 10.1002/pbc.21219. Pediatr Blood Cancer. 2008. PMID: 17427234
Cited by
-
Adrenal Tumors in Children and Adolescents in Sweden: A Register-Based Study Covering 15 Years.J Endocr Soc. 2025 Apr 2;9(5):bvaf058. doi: 10.1210/jendso/bvaf058. eCollection 2025 May. J Endocr Soc. 2025. PMID: 40226520 Free PMC article.
-
Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil.PLoS One. 2011 Mar 22;6(3):e18015. doi: 10.1371/journal.pone.0018015. PLoS One. 2011. PMID: 21445348 Free PMC article.
-
Management and prognosis of adrenocortical tumors in children: can we find out an appropriate points-scoring system to predict prognosis?Pediatr Surg Int. 2017 Jun;33(6):705-711. doi: 10.1007/s00383-017-4073-8. Epub 2017 Mar 4. Pediatr Surg Int. 2017. PMID: 28260193
-
Biological response of adrenal carcinoma and melanoma cells to mitotane treatment.Oncol Lett. 2022 Apr;23(4):120. doi: 10.3892/ol.2022.13240. Epub 2022 Feb 10. Oncol Lett. 2022. PMID: 35261634 Free PMC article.
-
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape.BMC Med Genomics. 2020 Nov 4;13(1):165. doi: 10.1186/s12920-020-00809-7. BMC Med Genomics. 2020. PMID: 33148256 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous